According to Gaikwad et al. [37], the lowest levels of nuclear NF-kB were observed after treatment of ovarian A2780 cells with CIS, whereas an increased expression of NF-kB was evident in paclitaxel-treated cells. This evidence concerns the gene NFKB1 and in situ carcinoma.